Loading...
Sialometabolism in Brain Health and Alzheimer’s Disease
Rawal, Punam Zhao, Liqin
Rawal, Punam
Zhao, Liqin
Citations
Altmetric:
Abstract
Sialic acids refer to a unique family of acidic sugars with a 9-carbon backbone that are mostly found as terminal residues in glycan structures of glycoconjugates including both glycoproteins and glycolipids. The highest levels of sialic acids are expressed in the brain where they regulate neuronal sprouting and plasticity, axon myelination and myelin stability, as well as remodeling of mature neuronal connections. Moreover, sialic acids are the sole ligands for microglial Siglecs (sialic acid-binding immunoglobulin-type lectins), and sialic acid-Siglec interactions have been indicated to play a critical role in the regulation of microglial homeostasis in a healthy brain. The recent discovery of CD33, a microglial Siglec, as a novel genetic risk factor for late-onset Alzheimer’s disease (AD), highlights the potential role of sialic acids in the development of microglial dysfunction and neuroinflammation in AD. Apart from microglia, sialic acids have been found to be involved in several other major changes associated with AD. Elevated levels of serum sialic acids have been reported in AD patients. Alterations in ganglioside (major sialic acid carrier) metabolism have been demonstrated as an aggravating factor in the formation of amyloid pathology in AD. Polysialic acids are linear homopolymers of sialic acids and have been implicated to be an important regulator of neurogenesis that contributes to neuronal repair and recovery from neurodegeneration such as in AD. In summary, this article reviews current understanding of neural functions of sialic acids and alterations of sialometabolism in aging and AD brains. Furthermore, we discuss the possibility of looking at sialic acids as a promising novel therapeutic target for AD intervention.
Description
Date
2021-03-30
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Research
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Sialic acid, Sialylation, Ganglioside, Neural cell adhesion molecule, PSA-NCAM, Siglec, CD33, Late-onset Alzheimer’s disease
Citation
Rawal P and Zhao L (2021) Sialometabolism in Brain Health and Alzheimer’s Disease. Front. Neurosci. 15:648617. doi: 10.3389/fnins.2021.648617